This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2023)
Bepirovirsen
Clinical data
Other names
GSK3228836
Legal status
Legal status
Investigational
Identifiers
CAS Number
1403787-62-1
UNII
Z87O6SM01N
Bepirovirsen (GSK3228836) is an antisense oligonucleotide developed to treat hepatitis B infection.[1]
^Mak, Lung-Yi; Hui, Rex Wan-Hin; Fung, James; Seto, Wai-Kay; Yuen, Man-Fung (2 November 2023). "Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress". Expert Opinion on Investigational Drugs. 32 (11): 971–983. doi:10.1080/13543784.2023.2277389. PMID 37902953. S2CID 264672407.
Bepirovirsen (GSK3228836) is an antisense oligonucleotide developed to treat hepatitis B infection. Mak, Lung-Yi; Hui, Rex Wan-Hin; Fung, James; Seto,...